Cargando…
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
Advances in the treatment of malignant pleural mesothelioma (MPM) have been disappointing, despite the apparent need for new therapeutic options for this rare and devastating cancer. Drug resistance is common and surgical intervention has brought benefits only to a subset of patients. MPM is a heter...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776703/ https://www.ncbi.nlm.nih.gov/pubmed/35069219 http://dx.doi.org/10.3389/fphar.2021.806570 |